Los Angeles Capital Management LLC Sells 1,863 Shares of Axon Enterprise, Inc $AXON

Los Angeles Capital Management LLC trimmed its position in Axon Enterprise, Inc (NASDAQ:AXON) by 11.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 14,523 shares of the biotechnology company’s stock after selling 1,863 shares during the quarter. Los Angeles Capital Management LLC’s holdings in Axon Enterprise were worth $8,248,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Creative Financial Designs Inc. ADV bought a new stake in shares of Axon Enterprise in the fourth quarter worth about $28,000. New Millennium Group LLC bought a new stake in shares of Axon Enterprise in the third quarter worth about $29,000. Sound Income Strategies LLC increased its holdings in shares of Axon Enterprise by 550.0% in the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after purchasing an additional 44 shares during the last quarter. Camelot Portfolios LLC bought a new stake in shares of Axon Enterprise in the fourth quarter worth about $30,000. Finally, Lodestone Wealth Management LLC bought a new stake in shares of Axon Enterprise in the fourth quarter worth about $35,000. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Stock Down 3.1%

Shares of NASDAQ AXON opened at $471.06 on Tuesday. The company has a current ratio of 2.27, a quick ratio of 1.93 and a debt-to-equity ratio of 0.49. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $885.91. The stock has a market capitalization of $37.97 billion, a price-to-earnings ratio of 189.18, a P/E/G ratio of 8.84 and a beta of 1.45. The firm’s 50-day moving average price is $408.45 and its 200-day moving average price is $491.12.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings data on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The company had revenue of $807.35 million for the quarter, compared to analyst estimates of $778.91 million. During the same period in the prior year, the company posted $1.47 EPS. The firm’s revenue for the quarter was up 33.7% on a year-over-year basis. On average, equities research analysts anticipate that Axon Enterprise, Inc will post 1.82 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CEO Patrick W. Smith sold 20,000 shares of the stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $500.00, for a total value of $10,000,000.00. Following the sale, the chief executive officer directly owned 3,060,997 shares of the company’s stock, valued at $1,530,498,500. This represents a 0.65% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Caitlin Elizabeth Kalinowski sold 564 shares of the stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $478.97, for a total transaction of $270,139.08. Following the completion of the sale, the director directly owned 3,632 shares in the company, valued at $1,739,619.04. This trade represents a 13.44% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 39,344 shares of company stock worth $19,267,315 over the last three months. 4.20% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on AXON shares. Robert W. Baird set a $800.00 target price on Axon Enterprise in a report on Wednesday, February 25th. Zacks Research raised Axon Enterprise from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 19th. Citigroup restated a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, February 25th. Barclays decreased their target price on shares of Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating on the stock in a research report on Friday, May 8th. Finally, JPMorgan Chase & Co. upped their target price on shares of Axon Enterprise from $750.00 to $755.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $712.75.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.